Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
about
Biomarkers for nutrient intake with focus on alternative sampling techniquesOn the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug MonitoringDried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of TeriflunomideClinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsyQuantifying Isoniazid Levels in Small Hair Samples: A Novel Method for Assessing Adherence during the Treatment of Latent and Active TuberculosisMight ART Adherence Estimates Be Improved by Combining Biomarker and Self-Report Data?Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review.Understanding pharmacokinetics to improve tuberculosis treatment outcome.Repeated measures of inflammation, blood pressure, and heart rate variability associated with traffic exposures in healthy adultsUsing dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies.Clinical Application of Ambient Ionization Mass Spectrometry.Validation of a bioanalytical method for the quantification of a therapeutic peptide, ramoplanin, in human dried blood spots using LC-MS/MS.Application of dried blood spot sampling combined with LC-MS/MS for genotyping and phenotyping of CYP450 enzymes in healthy volunteers.Impact of internal standard addition on dried blood spot analysis in bioanalytical method development.Incurred sample reanalysis comparison of dried blood spots and plasma samples on the measurement of lopinavir in clinical samples.Dried matrix on paper disks: the next generation DBS microsampling technique for managing the hematocrit effect in DBS analysis.Rapid DNA extraction from dried blood spots on filter paper: potential applications in biobanking.Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate--a validated assay for the clinic.Gas chromatography-electron ionization-mass spectrometry quantitation of valproic acid and gabapentin, using dried plasma spots, for therapeutic drug monitoring in in-home medical care.Feasibility of self-sampled dried blood spot and saliva samples sent by mail in a population-based study.N-Glycan profiling of dried blood spotsA comprehensive review of the published assays for the quantitation of the immunosuppressant drug mycophenolic acid and its glucuronidated metabolites in biological fluids.Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.How to optimize the evaluation and use of antibiotics in neonatesValidation and Clinical Evaluation of a Novel Method To Measure Miltefosine in Leishmaniasis Patients Using Dried Blood Spot Sample Collection.Determination of efavirenz in human dried blood spots by reversed-phase high-performance liquid chromatography with UV detection.Pre-exposure prophylaxis for HIV infection: how antiretroviral pharmacology helps to monitor and improve adherenceComparison of the quantification of acetaminophen in plasma, cerebrospinal fluid and dried blood spots using high-performance liquid chromatography-tandem mass spectrometryThe role of population PK-PD modelling in paediatric clinical research.Microassay of drugs and modern measurement techniques.Dried blood spots, pharmacokinetic studies and better medicines for children.Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications.Functional proteomics: application of mass spectrometry to the study of enzymology in complex mixtures.Novel strategies for sample preparation in forensic toxicology.Dried blood spots in toxicology: from the cradle to the grave?Regulated drug bioanalysis for human pharmacokinetic studies and therapeutic drug management.Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions.Dried blood spots in bioanalysis of antimalarials: relevance and challenges in quantitative assessment of antimalarial drugs.State-of-the-art dried blood spot analysis: an overview of recent advances and future trends.Methods for pharmacokinetic analysis in young children.
P2860
Q26739783-A3BE3B93-825F-4BE9-BF1F-A485EFEFA29CQ27024074-E8CB3F74-291C-461D-90B6-625D3773B0C9Q28384411-866DB3EB-FC56-4F13-8EA2-2EAB9E2A6289Q28543246-A73C7691-2F94-46D1-8F60-51C18499937BQ28552186-190ACBB6-9AC3-4209-A5F5-27A111307DB3Q28555028-A8B2E47E-B33D-4238-92B9-E73070DBD9DDQ30249512-B59ED91B-088F-47D7-8717-898C12288DE9Q30411703-245D1178-751C-40B5-8D53-5839D29A0512Q30661346-6C38A718-FAE8-4D2B-970A-17662C03B37DQ30922388-97C5ACE7-7BF3-4942-999E-1E1BB4A03293Q33470132-36E39696-1EAB-4E49-A239-051A9835B902Q33770850-8B99479E-96EB-46B0-97A7-9B814D2BA148Q33810432-9893CFC5-AFF3-4532-938F-DBCD052B5261Q34051573-A05963D6-FC35-4EE3-9D5C-9A23B6453DDBQ34150242-E3A41519-AB57-424C-BD5D-EBADA9EE903AQ34402589-7DA77D34-BB5A-4BBD-B5C7-69C4456FFE56Q34800374-99A370F6-58E9-427A-8B16-D2B3D6AEF414Q35059104-435F4C77-38C0-465E-888F-6141784FB0CFQ35180197-FD7DD0E9-E299-4845-98C4-2C2F58C81843Q35595335-0A03BF09-2879-4237-BD3E-7B9B5CAEF6CFQ35675417-C0AFFC9B-D39D-46B2-A341-0F42ACC60341Q35893989-FF73CA9A-016C-41FB-AFFC-34F39162F0E9Q36364155-182545DC-63C9-4AEE-B5B6-0D8D658CE378Q36452369-0F9FE702-1956-4BD4-8736-11D0DB44D3C2Q36730131-2C0C5BAB-F0EC-4A5C-A2E5-F2743CBFD4EEQ37359919-683F1285-AB75-4D61-894D-463633BCB042Q37637073-50DF6086-68FD-4247-87E7-83CA8681E2F9Q37709919-8F289A2A-C355-4CF5-8BC2-35E918C7493BQ37719346-8D603547-E2DF-4F66-99C9-3C9E3B147766Q37841718-582B2728-DADA-4118-803D-4DFC35D79033Q37859735-936240A4-1139-48AE-B88C-D7E201680F09Q37894587-15974F98-2C0F-4261-9E68-1CA489432B78Q37902554-DFDCF6D3-94E9-4DA1-800D-5ED14C029D21Q37928684-6E443CF5-E758-4FA2-AF1F-E448441DE03CQ37986127-386900F7-D120-4E80-953E-E864FCC83051Q38040177-FB915272-7533-4567-A2AD-B60F039F9187Q38128343-C4B3612C-E2BA-4CAB-A1F8-A88E98675B7CQ38130331-8732771E-8264-47D6-A6E4-C7ECE3EF1A4EQ38130332-FF1D84E9-D280-4630-AEE9-0644676F7864Q38187157-E8532308-17AB-4E3E-BB61-D9663BCD4500
P2860
Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
@en
Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
@nl
type
label
Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
@en
Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
@nl
prefLabel
Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
@en
Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
@nl
P2093
P1476
Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
@en
P2093
Jacques van der Heijden
Leo M L Stolk
Peter M Edelbroek
P304
P356
10.1097/FTD.0B013E31819E91CE
P577
2009-06-01T00:00:00Z